UK Renal Registry 18th Annual Report: Chapter 8 Haemoglobin, Ferritin and Erythropoietin amongst UK Adult Dialysis Patients in 2014: National and Centre-specific Analyses.
In the UK in 2014: The median haemoglobin (Hb) of patients at the time of starting dialysis was 100 g/L with 50% of patients having a Hb 5100 g/L. The median Hb in patients starting haemodialysis (HD) was 97 g/L (IQR 87-106) and in patients starting peritoneal dialysis (PD) was 108 g/L (IQR 100-117). At start of dialysis, 54% of patients presenting early had Hb 5100 g/L whilst only 33% of patients presenting late had Hb 5100 g/L. The median Hb of prevalent patients on HD was 111 g/L with an IQR of 103-120 g/L. The median Hb of prevalent patients on PD was 112 g/L with an IQR of 103-121 g/L. 81% of HD patients and 83% of PD patients had Hb 5100 g/L. 58% of HD patients and 56% of PD patients had Hb 5100 and 4120 g/L. The median ferritin in HD patients was 432 mg/L (IQR 274–631) and 95% of HD patients had a ferritin 5100 mg/L. The median ferritin in PD patients was 292 mg/L (IQR 168–479) with 88% of PD patients having a ferritin 5100 mg/L. In England, Wales and Northern Ireland in 2014: The median erythropoietin stimulating agent (ESA) dose was higher for HD than PD patients (7,333 vs. 4,148 IU/week).
UK Renal Registry, Bristol, UK.
Julie
J
Gilg
Anirudh
A
Rao
Andrew J
AJ
Williams
D004921:Erythropoietin / Q000378:metabolism*; D005293:Ferritins / Q000378:metabolism*; D006454:Hemoglobins / Q000378:metabolism*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000097:blood* / Q000453:epidemiology / Q000628:therapy; D012042:Registries; D006435:Renal Dialysis; D006113:United Kingdom / Q000453:epidemiology
D006454:Hemoglobins; D004921:Erythropoietin; D005293:Ferritins